Pricing Log in Create free account

Nanobiotix S.A. - Sponsored ADR (NBTX) vs SELLAS Life Sciences Group, Inc. (SLS)

Nanobiotix S.A. - Sponsored ADR and SELLAS Life Sciences Group, Inc. are both Biotechnology companies. Nanobiotix S.A. - Sponsored ADR and SELLAS Life Sciences Group, Inc. are of similar size ($1.6B and $1.5B). Across the 9 metrics below, SELLAS Life Sciences Group, Inc. leads on 6 and Nanobiotix S.A. - Sponsored ADR on 3.

Valuation

Metric NBTX SLS Biotechnology median
P/E n/m n/m 10.60
P/S 6,111.93 149.37 9.40
P/B n/m 11.39 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 5,356.43 136.22 9.02
Earnings yield (10.85%) (2.53%) (32.88%)
Free cash flow yield (13.68%) (2.45%) (23.13%)

Profitability

Metric NBTX SLS Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (39.63%) (51.96%)
Return on assets 0.00% (36.54%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NBTX SLS Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 63.46% 50.00% 29.88%
Revenue growth, 5-year CAGR 66.64% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NBTX SLS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.44 18.83 4.97
Net debt to EBITDA 5.66 2.54 1.01

Dividend

Metric NBTX SLS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NBTX SLS Biotechnology median
Market cap 1.53b 1.59b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack